Ruffer LLP Amgen Inc Transaction History

Ruffer LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $2.11 Million - $2.79 Million	-11,561 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $188 Million - $241 Million	-991,194 Reduced 98.85%	11,561 $2.79 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $7.59 Million - $9.09 Million	-43,585 Reduced 4.17%	1,002,755 $194 Million
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $174 Million - $204 Million	1,046,340 New	1,046,340 $193 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

Stay updated on Ruffer LLP with notifications on news.